abrdn plc Sells 9,686 Shares of CME Group Inc. (NASDAQ:CME)

abrdn plc lessened its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 650,673 shares of the financial services provider’s stock after selling 9,686 shares during the period. abrdn plc owned 0.18% of CME Group worth $142,227,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of CME. Aviance Capital Partners LLC purchased a new position in shares of CME Group in the 1st quarter worth about $525,000. Miracle Mile Advisors LLC raised its position in CME Group by 11.5% in the 1st quarter. Miracle Mile Advisors LLC now owns 3,576 shares of the financial services provider’s stock worth $770,000 after buying an additional 368 shares during the last quarter. Capital Advisors Ltd. LLC raised its position in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in CME Group by 0.3% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 989,765 shares of the financial services provider’s stock worth $213,086,000 after buying an additional 2,527 shares during the last quarter. Finally, Valley National Advisers Inc. raised its position in CME Group by 57.8% in the 1st quarter. Valley National Advisers Inc. now owns 1,368 shares of the financial services provider’s stock worth $293,000 after buying an additional 501 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on CME shares. Deutsche Bank Aktiengesellschaft boosted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Morgan Stanley boosted their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Finally, Barclays boosted their price target on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $222.73.

CME Group Trading Up 0.9 %

CME stock opened at $228.12 on Tuesday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $82.14 billion, a price-to-earnings ratio of 25.95, a PEG ratio of 7.76 and a beta of 0.55. The business has a 50 day simple moving average of $219.32 and a two-hundred day simple moving average of $208.98.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company posted $2.25 EPS. Research analysts anticipate that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group’s dividend payout ratio (DPR) is 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.